Get started
Abeona Therapeutics Inc.Abeona Therapeutics Inc.Abeona Therapeutics Inc.

Abeona Therapeutics Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

ABEO chart

Key stats

Market capitalization
‪208.99 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.59USD
Net income
‪−54.19 M‬USD
Revenue
‪3.50 M‬USD
Shares float
‪25.91 M‬
Beta (1Y)
0.25

About Abeona Therapeutics Inc.

Sector
Health Technology
CEO
Vishwas Seshadri
Headquarters
Cleveland
Website
abeonatherapeutics.com
Employees (FY)
84
Founded
1974
ISIN
US00289Y2063
FIGI
BBG000DT5D52
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ABEO is 7.76 USD — it has increased by 1.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Abeona Therapeutics Inc. stocks are traded under the ticker ABEO.
Abeona Therapeutics Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Abeona Therapeutics Inc. has a max estimate of 36.00 USD and a min estimate of 12.00 USD.
ABEO earnings for the last quarter are −0.48 USD whereas the estimation was −0.53 USD which accounts for 10.00% surprise. Estimated earnings for the next quarter are −0.47 USD. See more details about Abeona Therapeutics Inc. earnings.
Abeona Therapeutics Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪1.00 M‬ USD.
Yes, you can track Abeona Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ABEO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Abeona Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
ABEO reached its all-time high on May 22, 1981 with the price of 5437500.00 USD, and its all-time low was 2.19 USD and was reached on Feb 24, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 84.00 employees. See our rating of the largest employees — is Abeona Therapeutics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Abeona Therapeutics Inc. EBITDA is ‪−45.00 M‬ USD, and current EBITDA margin is ‪−1.29 K‬%. See more stats in Abeona Therapeutics Inc. financial statements.